RxElite, Inc.
RXEI
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | ||||
|---|---|---|---|---|---|
| Revenue | 8.37% | 0.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.37% | 0.22% | |||
| Cost of Revenue | 17.89% | -5.25% | |||
| Gross Profit | -39.03% | 40.69% | |||
| SG&A Expenses | -5.64% | 41.07% | |||
| Depreciation & Amortization | 12.42% | -5.77% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.48% | 11.08% | |||
| Operating Income | -2.65% | -24.25% | |||
| Income Before Tax | -71.62% | 9.24% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -71.62% | 9.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -71.62% | 9.24% | |||
| EBIT | -2.65% | -24.25% | |||
| EBITDA | 2.60% | -25.30% | |||
| EPS Basic | -71.40% | 10.29% | |||
| Normalized Basic EPS | 22.25% | 18.78% | |||
| EPS Diluted | -71.40% | 10.29% | |||
| Normalized Diluted EPS | 22.25% | 18.78% | |||
| Average Basic Shares Outstanding | 0.19% | 1.07% | |||
| Average Diluted Shares Outstanding | 0.19% | 1.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||